Association of the Metabolic Syndrome with Atrial Fibrillation Among United States Adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)

Overview

Journal Am J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2011 May 3

PMID 21530935

Citations 32

Authors

Rikki M Tanner

Usman Baber

April P Carson

Jenifer Voeks

Todd M Brown

Elsayed Z Soliman

Virginia J Howard

Paul Muntner

Affiliations

Soon will be listed here.

Abstract

Metabolic syndrome (MS) and atrial fibrillation (AF) are associated with increased cardiovascular disease morbidity and mortality. This analysis evaluated the association between MS and AF in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. MS was defined using criteria recommended in the joint interim statement from several international societies. AF was defined by electrocardiogram (ECG) and/or self-report and by ECG alone. In patients with 0, 1, 2, 3, 4, and 5 MS components, prevalences of AF by ECG and/or self-report were 5.5%, 7.7%, 8.2%, 9.2%, 9.6%, and 11.5%, respectively (p for trend <0.001). After multivariable adjustment, each MS component except serum triglycerides was significantly associated with AF. The multivariable-adjusted odds ratio for AF, defined by ECG and/or or self-reported history, comparing those with to those without MS was 1.20 (95% confidence interval 1.10 to 1.29). Results were consistent when AF was defined by ECG alone (odds ratio 1.15, 95% confidence interval 0.92 to 1.39). In conclusion, MS is associated with an increased prevalence of AF. Further studies investigating a potential mechanism for this excess risk are warranted.

Citing Articles

The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.

Fekete M, Liotta E, Molnar T, Fulop G, Lehoczki A Geroscience. 2024; 47(1):287-300.

PMID: 39138793 PMC: 11872872. DOI: 10.1007/s11357-024-01290-1.

Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome.

Lee H, Cheng W, Ma W, Lin Y, Shin S, Lin Y Sci Rep. 2023; 13(1):6575.

PMID: 37085694 PMC: 10121655. DOI: 10.1038/s41598-023-33757-0.

Benefits of SGLT2 inhibitors in arrhythmias.

Gao J, Xue G, Zhan G, Wang X, Li J, Yang X Front Cardiovasc Med. 2022; 9:1011429.

PMID: 36337862 PMC: 9631490. DOI: 10.3389/fcvm.2022.1011429.

QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype.

Lee M, Wang Y, Li Y, Tsai C, Chen S, Jhuang W Int J Gen Med. 2022; 15:6189-6198.

PMID: 35874912 PMC: 9296885. DOI: 10.2147/IJGM.S361705.

Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study.

Lee S, Lee S, Choi E, Kwon S, Yang S, Park J J Am Heart Assoc. 2021; 10(16):e020901.

PMID: 34369167 PMC: 8475027. DOI: 10.1161/JAHA.121.020901.

References

Annoura M, Ogawa M, Kumagai K, Zhang B, Saku K, Arakawa K . Cholesterol paradox in patients with paroxysmal atrial fibrillation. Cardiology. 2000; 92(1):21-7. DOI: 10.1159/000006942. View

Soliman E, Howard G, Prineas R, McClure L, Howard V . Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study. J Electrocardiol. 2009; 43(3):209-14. PMC: 2856789. DOI: 10.1016/j.jelectrocard.2009.10.002. View

Benjamin E, Levy D, Vaziri S, DAgostino R, Belanger A, Wolf P . Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271(11):840-4. View

Zhang X, Zhang S, Li Y, Detrano R, Chen K, Li X . Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes (Lond). 2009; 33(11):1318-25. DOI: 10.1038/ijo.2009.157. View

Psaty B, Manolio T, Kuller L, Kronmal R, Cushman M, Fried L . Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96(7):2455-61. DOI: 10.1161/01.cir.96.7.2455. View

Krishnamoorthy S, Lip G . Hypertension, stroke and the impact of atrial fibrillation. Expert Rev Cardiovasc Ther. 2008; 6(10):1287-9. DOI: 10.1586/14779072.6.10.1287. View

Howard V, Cushman M, Pulley L, Gomez C, Go R, Prineas R . The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005; 25(3):135-43. DOI: 10.1159/000086678. View

Kannel W, Wolf P, Benjamin E, Levy D . Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82(8A):2N-9N. DOI: 10.1016/s0002-9149(98)00583-9. View

Chamberlain A, Agarwal S, Ambrose M, Folsom A, Soliman E, Alonso A . Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010; 159(5):850-6. PMC: 2864775. DOI: 10.1016/j.ahj.2010.02.005. View

10.

Inoue H, Nozawa T, Hirai T, Goto S, Origasa H, Shimada K . Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE. Circ J. 2010; 74(4):650-4. DOI: 10.1253/circj.cj-09-0802. View

11.

Tang R, Gao L, Dong J, Liu X, Liu X, Wu J . Metabolic syndrome in patients with atrial fibrillation in the absence of structural heart disease from a tertiary hospital in China. Chin Med J (Engl). 2009; 122(22):2744-7. View

12.

Nichols G, Reinier K, Chugh S . Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009; 32(10):1851-6. PMC: 2752931. DOI: 10.2337/dc09-0939. View

13.

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

14.

Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden D, Sasaki S . Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008; 117(10):1255-60. PMC: 2637133. DOI: 10.1161/CIRCULATIONAHA.107.744466. View

15.

Diaz-Peromingo J, Alban-Salgado A, Garcia-Suarez F, Sanchez-Leira J, Saborido-Frojan J, Iglesias-Gallego M . Lipoprotein(a) and lipid profile in patients with atrial fibrillation. Med Sci Monit. 2006; 12(3):CR122-5. View

16.

Johansen O, Brustad E, Enger S, Tveit A . Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects. Cardiovasc Diabetol. 2008; 7:28. PMC: 2564913. DOI: 10.1186/1475-2840-7-28. View

17.

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

18.

Suzuki T, Katz R, Jenny N, Zakai N, LeWinter M, Barzilay J . Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2009; 1(4):242-8. PMC: 2762642. DOI: 10.1161/CIRCHEARTFAILURE.108.785485. View

19.

Prineas R, Soliman E, Howard G, Howard V, Cushman M, Zhang Z . The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study. J Epidemiol. 2009; 19(4):177-81. PMC: 2750004. DOI: 10.2188/jea.je20081032. View

20.

Furberg C, Psaty B, Manolio T, Gardin J, Smith V, Rautaharju P . Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994; 74(3):236-41. DOI: 10.1016/0002-9149(94)90363-8. View